O
PBH icon

OppenheimerFunds’s Prestige Consumer Healthcare PBH Stock Holding History

OppenheimerFunds’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$260K Buy
8,698
+1,232
+17% +$35.3K ﹤0.01% 1609
2018
Q4 		$231K Sell
7,466
-145
-2% -$5.29K ﹤0.01% 1678
2018
Q3 		$288K Sell
7,611
-894
-11% -$33.8K ﹤0.01% 1672
2018
Q2 		$326K Sell
8,505
-653,461
-99% -$22M ﹤0.01% 1587
2018
Q1 		$22.3M Sell
661,966
-284,065
-30% -$10.9M 0.03% 538
2017
Q4 		$42M Buy
946,031
+40,633
+4% +$1.85M 0.05% 355
2017
Q3 		$45.4M Sell
905,398
-44,139
-5% -$2.26M 0.06% 323
2017
Q2 		$50.1M Buy
949,537
+99,652
+12% +$5.34M 0.06% 294
2017
Q1 		$47.2M Buy
849,885
+27,129
+3% +$1.5M 0.06% 319
2016
Q4 		$42.9M Sell
822,756
-48,224
-6% -$2.33M 0.05% 360
2016
Q3 		$42M Sell
870,980
-86,499
-9% -$4.37M 0.05% 374
2016
Q2 		$53M Sell
957,479
-17,690
-2% -$974K 0.07% 300
2016
Q1 		$52.1M Buy
975,169
+374,975
+62% +$18.5M 0.07% 305
2015
Q4 		$30.9M Sell
600,194
-163,656
-21% -$8.13M 0.04% 446
2015
Q3 		$34.5M Buy
763,850
+30,570
+4% +$1.44M 0.05% 408
2015
Q2 		$33.9M Sell
733,280
-436,221
-37% -$19.1M 0.04% 448
2015
Q1 		$50.2M Buy
1,169,501
+23,361
+2% +$890K 0.06% 372
2014
Q4 		$39.8M Buy
1,146,140
+260,103
+29% +$8.63M 0.04% 412
2014
Q3 		$28.7M Buy
886,037
+6,645
+0.8% +$222K 0.03% 478
2014
Q2 		$29.8M Buy
879,392
+151,623
+21% +$4.86M 0.03% 479
2014
Q1 		$19.8M Buy
+727,769
New +$21.6M 0.02% 576

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

OppenheimerFunds's PBH Position: Q1 2019 in Review

OppenheimerFunds increased its Prestige Consumer Healthcare (PBH) stake by 17% in Q1 2019, buying an estimated $35.3K and bringing the position to 8,698 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

OppenheimerFunds first reported a position in PBH in Q1 2014 and has held it in 21 quarters since. The position peaked at $53M in Q2 2016. 221 funds tracked by Wall St. Rank hold PBH as of Q1 2019.

  • OppenheimerFunds held 8,698 shares of Prestige Consumer Healthcare worth $260K as of Q1 2019.
  • OppenheimerFunds bought 1,232 Prestige Consumer Healthcare shares in Q1 2019, an estimated $35.3K.
  • Prestige Consumer Healthcare made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1609 holding.
  • OppenheimerFunds first reported a position in Prestige Consumer Healthcare in Q1 2014 and has held it in 21 quarters since.
  • OppenheimerFunds's Prestige Consumer Healthcare position peaked at $53M in Q2 2016.
  • 221 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.